Copyright Reports & Markets. All rights reserved.

Global Companion Animal Pharmaceutical Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
    • 1.2.2 Infectious Diseases
    • 1.2.3 Dermatologic Diseases
    • 1.2.4 Pain
    • 1.2.5 Orthopedic Diseases
    • 1.2.6 Behavioral Diseases
    • 1.2.7 Other Indications
  • 1.3 Market by Application
    • 1.3.1 Global Companion Animal Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Dogs
    • 1.3.3 Cats
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Companion Animal Pharmaceutical Market Perspective (2016-2027)
  • 2.2 Companion Animal Pharmaceutical Growth Trends by Regions
    • 2.2.1 Companion Animal Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Companion Animal Pharmaceutical Historic Market Share by Regions (2016-2021)
    • 2.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Regions (2022-2027)
  • 2.3 Companion Animal Pharmaceutical Industry Dynamic
    • 2.3.1 Companion Animal Pharmaceutical Market Trends
    • 2.3.2 Companion Animal Pharmaceutical Market Drivers
    • 2.3.3 Companion Animal Pharmaceutical Market Challenges
    • 2.3.4 Companion Animal Pharmaceutical Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Animal Pharmaceutical Players by Revenue
    • 3.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2016-2021)
    • 3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2016-2021)
  • 3.2 Global Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Companion Animal Pharmaceutical Revenue
  • 3.4 Global Companion Animal Pharmaceutical Market Concentration Ratio
    • 3.4.1 Global Companion Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Pharmaceutical Revenue in 2020
  • 3.5 Companion Animal Pharmaceutical Key Players Head office and Area Served
  • 3.6 Key Players Companion Animal Pharmaceutical Product Solution and Service
  • 3.7 Date of Enter into Companion Animal Pharmaceutical Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Animal Pharmaceutical Breakdown Data by Indication

  • 4.1 Global Companion Animal Pharmaceutical Historic Market Size by Indication (2016-2021)
  • 4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Indication (2022-2027)

5 Companion Animal Pharmaceutical Breakdown Data by Application

  • 5.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2016-2021)
  • 5.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Companion Animal Pharmaceutical Market Size (2016-2027)
  • 6.2 North America Companion Animal Pharmaceutical Market Size by Indication
    • 6.2.1 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
    • 6.2.2 North America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
    • 6.2.3 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
  • 6.3 North America Companion Animal Pharmaceutical Market Size by Application
    • 6.3.1 North America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
    • 6.3.2 North America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
    • 6.3.3 North America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
  • 6.4 North America Companion Animal Pharmaceutical Market Size by Country
    • 6.4.1 North America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
    • 6.4.2 North America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Companion Animal Pharmaceutical Market Size (2016-2027)
  • 7.2 Europe Companion Animal Pharmaceutical Market Size by Indication
    • 7.2.1 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
    • 7.2.2 Europe Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
    • 7.2.3 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
  • 7.3 Europe Companion Animal Pharmaceutical Market Size by Application
    • 7.3.1 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2021)
    • 7.3.2 Europe Companion Animal Pharmaceutical Market Size by Application (2022-2027)
    • 7.3.3 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2027)
  • 7.4 Europe Companion Animal Pharmaceutical Market Size by Country
    • 7.4.1 Europe Companion Animal Pharmaceutical Market Size by Country (2016-2021)
    • 7.4.2 Europe Companion Animal Pharmaceutical Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2016-2027)
  • 8.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication
    • 8.2.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
    • 8.2.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
    • 8.2.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
  • 8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application
    • 8.3.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region
    • 8.4.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Companion Animal Pharmaceutical Market Size (2016-2027)
  • 9.2 Latin America Companion Animal Pharmaceutical Market Size by Indication
    • 9.2.1 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
    • 9.2.2 Latin America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
    • 9.2.3 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
  • 9.3 Latin America Companion Animal Pharmaceutical Market Size by Application
    • 9.3.1 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
    • 9.3.2 Latin America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
    • 9.3.3 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
  • 9.4 Latin America Companion Animal Pharmaceutical Market Size by Country
    • 9.4.1 Latin America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
    • 9.4.2 Latin America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2016-2027)
  • 10.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication
    • 10.2.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
    • 10.2.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
    • 10.2.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
  • 10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application
    • 10.3.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country
    • 10.4.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Details
    • 11.1.2 Zoetis Business Overview
    • 11.1.3 Zoetis Companion Animal Pharmaceutical Introduction
    • 11.1.4 Zoetis Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.1.5 Zoetis Recent Development
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Company Details
    • 11.2.2 Boehringer Ingelheim Business Overview
    • 11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Introduction
    • 11.2.4 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.2.5 Boehringer Ingelheim Recent Development
  • 11.3 Merck Animal Health
    • 11.3.1 Merck Animal Health Company Details
    • 11.3.2 Merck Animal Health Business Overview
    • 11.3.3 Merck Animal Health Companion Animal Pharmaceutical Introduction
    • 11.3.4 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.3.5 Merck Animal Health Recent Development
  • 11.4 Elanco Animal Health
    • 11.4.1 Elanco Animal Health Company Details
    • 11.4.2 Elanco Animal Health Business Overview
    • 11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Introduction
    • 11.4.4 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.4.5 Elanco Animal Health Recent Development
  • 11.5 Bayer Animal Health
    • 11.5.1 Bayer Animal Health Company Details
    • 11.5.2 Bayer Animal Health Business Overview
    • 11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Introduction
    • 11.5.4 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.5.5 Bayer Animal Health Recent Development
  • 11.6 Virbac
    • 11.6.1 Virbac Company Details
    • 11.6.2 Virbac Business Overview
    • 11.6.3 Virbac Companion Animal Pharmaceutical Introduction
    • 11.6.4 Virbac Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.6.5 Virbac Recent Development
  • 11.7 Dechra Veterinary Products
    • 11.7.1 Dechra Veterinary Products Company Details
    • 11.7.2 Dechra Veterinary Products Business Overview
    • 11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Introduction
    • 11.7.4 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.7.5 Dechra Veterinary Products Recent Development
  • 11.8 Ceva
    • 11.8.1 Ceva Company Details
    • 11.8.2 Ceva Business Overview
    • 11.8.3 Ceva Companion Animal Pharmaceutical Introduction
    • 11.8.4 Ceva Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.8.5 Ceva Recent Development
  • 11.9 Vetoquinol
    • 11.9.1 Vetoquinol Company Details
    • 11.9.2 Vetoquinol Business Overview
    • 11.9.3 Vetoquinol Companion Animal Pharmaceutical Introduction
    • 11.9.4 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.9.5 Vetoquinol Recent Development
  • 11.10 Meiji
    • 11.10.1 Meiji Company Details
    • 11.10.2 Meiji Business Overview
    • 11.10.3 Meiji Companion Animal Pharmaceutical Introduction
    • 11.10.4 Meiji Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.10.5 Meiji Recent Development
  • 11.11 Ouro Fino Saude
    • 11.11.1 Ouro Fino Saude Company Details
    • 11.11.2 Ouro Fino Saude Business Overview
    • 11.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Introduction
    • 11.11.4 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.11.5 Ouro Fino Saude Recent Development
  • 11.12 Parnell
    • 11.12.1 Parnell Company Details
    • 11.12.2 Parnell Business Overview
    • 11.12.3 Parnell Companion Animal Pharmaceutical Introduction
    • 11.12.4 Parnell Revenue in Companion Animal Pharmaceutical Business (2016-2021)
    • 11.12.5 Parnell Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Companion Animal Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Animal Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Indication and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Indication
    Infectious Diseases
    Dermatologic Diseases
    Pain
    Orthopedic Diseases
    Behavioral Diseases
    Other Indications

    Segment by Application
    Dogs
    Cats
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Bayer Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell

    Buy now